Membrane/Core Nanoparticles for Delivery of Therapeutic Nucleic Acid - Nanotechnology for the Delivery of Therapeutic Nucleic Acids - page 88

100. John, C.S., ., A malignant melanoma imaging agent: synthesis,

characterization,

et al

binding and biodistribution of iodine-
125-(2-piperidinylaminoethyl)4-iodobenzamide.

in vitro

J Nucl Med , 1993.

(12): pp. 2169-2175.
101. John, C.S.,

34

pharmacoki-
netics of [125I]N-[2-(4-iodophenyl)ethyl]-N-methyl-2-(1-piperidinyl)
ethylamine: a high-affinity ligand for imaging sigma receptor positive
tumors.

et al ., Synthesis, in vitro validation and in vivo

(6): pp. 761-766.
102. John, C.S., B.J. Vilner, and W.D. Bowen, Synthesis and characterization
of [125I]-N-(N-benzylpiperidin-4-yl)-4- iodobenzamide, a new sigma
receptor radiopharmaceutical: high-affinity binding to MCF-7 breast
tumor cells.

Nucl Med Biol , 1996. 23

J Med Chem , 1994. 37 (12): pp. 1737-1739.

103. John, C.S., ., Synthesis and pharmacological characterization of 4-

[125I]-N-(N-benzylpiperidin-4-yl)-4-iodobenzamide: a high affinity
sigma receptor ligand for potential imaging of breast cancer.

et al

Cancer

(14): pp. 3022-3027.
104. Vilner, B.J., C.S. John, and W.D. Bowen, Sigma-1 and sigma-2 receptors
are expressed in a wide variety of human and rodent tumor cell lines.
Cancer Res

Res , 1995. 55

, 1995. 55 (2): pp. 408-413.

105. Walker, J.M., et al ., Sigma receptors: biology and function. Pharmacol

Rev , 1990. 42 (4): pp. 355-402.

106. Banerjee, R., ., Anisamide-targeted stealth liposomes: a potent

carrier for targeting doxorubicin to human prostate cancer cells.

et al

Int J

(4): pp. 693-700.
107. Li, S.D., S. Chono, and L. Huang, Efficient gene silencing in metastatic
tumor by siRNA formulated in surface-modified nanoparticles.

Cancer , 2004. 112

J

Control Release , 2008. 126 (1): pp. 77-84.

108. Zhu, X., ., Identification of internalizing human single-chain

antibodies targeting brain tumor sphere cells.

et al

Mol Cancer Ther , 2010.

(7): pp. 2131-2141.
109. Pirollo, K.F., and E.H. Chang, Does a targeting ligand influence
nanoparticle tumor localization or uptake?

9

Trends Biotechnol , 2008.

(10): pp. 552-558.
110. Bartlett, D.W.,

26

., Impact of tumor-specific targeting on the
biodistribution and efficacy of siRNA nanoparticles measured by
multimodality

et al

in vivo imaging. Proc Natl Acad Sci USA , 2007. 104 (39):

pp. 15549-15554.